Abstract
The influence of probenecid administration on 5HIAA and HVA concentrations in the CSF of depressed patients, was studied before and after treatment with imipramine or ECT.
The average increase of the two metabolites in the CSF after probenecid was similar in the untreated depressed patients and in the same patients improved after both imipramine or ECT treatment.
The treatment determined a significant increase in the CSF concentration of the acid metabolites also before the probenecid administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bowers, M. B., Jr.: Cerebrospinal fluid 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with ami-triptyline. Psychopharmacologia (Berl.) 23, 26–33 (1972a)
Bowers, M. B., Jr.: Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: realibility and interpretation of cerebrospinal fluid acid monoamine metabolite measures. Neuropharmacology 11, 101–111 (1972b)
Bowers, M. B., Jr., Heninger, G. R., Gerbode, F.: Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients. Int. J. Neuropharmacol. 8, 255–262 (1969)
Bulat, M., Živković, B.: Origin of 5-hydroxyindoleacetic acid in the spinal fluid. Science 173, 738–740 (1971)
Bulat, M., Živkovic, B.: Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier. J. Pharm. Pharmacol. 25, 178–179 (1973)
Garattini, S., Kato, R., Valzelli, L.: Biochemical and pharmacological effects induced by electroshock. Psychiat. et Neurol. (Basel) 140, 190–206 (1960)
Giacalone, E., Valzelli, L.: A spectrofluorometric method for the simultaneous determination of 2-(5-hydroxyindol-3yl) thylamine (serotonin) and 5-hydroxyindol-3-yl acetic acid in the brain. Pharmacology (Basel) 2, 171–175 (1969)
Goodwin, F. K., Sack, R. L.: Affective disorders: the catecholamine hypothesis revisited. In: Frontiers in catecholamine research, E. Usdin and S. H. Snyder, eds., pp. 1157–1164. New York: Pergamon Press 1973
Jori, A., Kemali, D., Vacca, L., Del Vecchio, M.: Metabolism of biogenic amines in chronic familial schizophrenias. In: International Symposium of Neurochemistry, Tokyo, p. 467, 1973
Korf, J., Van Praag, H. M.: Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Res. 35, 221–230 (1971)
Korf, J., Van Praag, H. M., Sebens, J. B.: Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in cerebrospinal fluid. Biochem. Pharmacol. 20, 659–668 (1971)
Papeschi, R., McClure, D. J.: Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. gen. Psychiat. 25, 354–358 (1971)
Roos, B.-E., Sjöström, R.: 5-Hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychoses. Pharmacol. Clin. 1, 153–155 (1969)
Sjöström, R., Roos, B.-E.: 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis. Europ. J. clin. Pharmacol. 4, 170–176 (1972)
Tagliamonte, A., Tagliamonte, P., Di Chiara, G., Maffei, C., Gessa, R., Gessa, G. L.: Effect of electroconvulsive shock on brain tryptophan in rats. Riv. Farmacol. Ter. 2, 195 to 199 (1971)
Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, pt. I, 1397–1408 (1970a)
Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) in human cerebral spinal fluid following probenecid administration. Pharmacologist 12, 198 (1970b)
Van Praag, H. M., Korf, J.: Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia (Berl.) 19, 148–152 (1971)
Van Praag, H. M., Korf, J.: Cerebral monoamines and depression. Arch. gen. Psychiat. 28, 827–831 (1973)
Van Praag, H. M., Korf, J., Puite, J.: 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (Lond.) 225, 1259–1260 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jori, A., Dolfini, E., Casati, C. et al. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients. Psychopharmacologia 44, 87–90 (1975). https://doi.org/10.1007/BF00421189
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421189